Trends in the incidence of treated end-stage renal failure in The Netherlands: Hope for the future?
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 66 (92) , S7-S10
- https://doi.org/10.1111/j.1523-1755.2004.09202.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Contribution of Increased Diabetes Prevalence and Improved Myocardial Infarction and Stroke Survival to the Increase in Treated End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2003
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United StatesAmerican Journal of Kidney Diseases, 2001
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensionsAmerican Journal of Kidney Diseases, 1999
- The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal DiseaseNew England Journal of Medicine, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Selective effect of low protein diets in chronic renal diseases.BMJ, 1984